The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Safety and antiemetic effect of palonosetron for chemoradiation therpy of esophageal cancer.
Yasushi Ichikawa
No relevant relationships to disclose
Ayumu Goto
No relevant relationships to disclose
Noritoshi Kobayashi
No relevant relationships to disclose
Motohiko Tokuhisa
No relevant relationships to disclose
Takashi Ishikawa
No relevant relationships to disclose
Hirochika Makino
No relevant relationships to disclose
Takashi Kosaka
No relevant relationships to disclose
Hirotoshi Akiyama
No relevant relationships to disclose
Chikara Kunisaki
No relevant relationships to disclose
Shin Maeda
No relevant relationships to disclose
Itaru Endo
No relevant relationships to disclose